ProShare Advisors’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $187K | Buy |
12,479
+1,101
| +10% | +$16.5K | ﹤0.01% | 1740 |
|
|
2025
Q1 | $184K | Sell |
11,378
-1,153
| -9% | -$18.6K | ﹤0.01% | 1715 |
|
|
2024
Q4 | $292K | Buy |
+12,531
| New | +$292K | ﹤0.01% | 1654 |
|
|
2022
Q2 | – | Sell |
-507
| Closed | -$29K | – | 2102 |
|
|
2022
Q1 | $29K | Sell |
507
-124
| -20% | -$7.09K | ﹤0.01% | 2154 |
|
|
2021
Q4 | $75K | Buy |
631
+5
| +0.8% | +$594 | ﹤0.01% | 2238 |
|
|
2021
Q3 | $124K | Sell |
626
-146
| -19% | -$28.9K | ﹤0.01% | 1881 |
|
|
2021
Q2 | $134K | Buy |
772
+24
| +3% | +$4.17K | ﹤0.01% | 2239 |
|
|
2021
Q1 | $148K | Buy |
748
+52
| +7% | +$10.3K | ﹤0.01% | 2109 |
|
|
2020
Q4 | $137K | Buy |
696
+203
| +41% | +$40K | ﹤0.01% | 1939 |
|
|
2020
Q3 | $87K | Sell |
493
-20
| -4% | -$3.53K | ﹤0.01% | 1536 |
|
|
2020
Q2 | $119K | Buy |
+513
| New | +$119K | ﹤0.01% | 1550 |
|
|
2019
Q4 | – | Sell |
-432
| Closed | -$83K | – | 1801 |
|
|
2019
Q3 | $83K | Buy |
432
+14
| +3% | +$2.69K | ﹤0.01% | 1567 |
|
|
2019
Q2 | $72K | Sell |
418
-38
| -8% | -$6.55K | ﹤0.01% | 1558 |
|
|
2019
Q1 | $92K | Buy |
+456
| New | +$92K | ﹤0.01% | 1581 |
|